Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: American Society of Ophthalmic Plastic and Reconstructive Surgery 57th Annual Fall Scientific Symposium

October 12, 2026

Raymond Douglas, MD, PhD, Unveils Research on Six-Week Teprotumumab Dosing to Help Protect Hearing

LOS ANGELES, Oct. 12, 2026 /PRNewswire/ — Raymond Douglas, MD, PhD, a lead scientist behind the first FDA-approved treatment for thyroid eye disease (TED) and a 2026 ASOPRS Outstanding Contribution Award recipient, presented research at the American Society of Ophthalmic Plastic and… Source: Read More

Announcements

2026 ASOPRS Outstanding Contribution Award, American Society of Ophthalmic Plastic and Reconstructive Surgery 57th Annual Fall Scientific Symposium, ASOPRS, pr-newswire, TED, Teprotumumab, thyroid eye disease

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Subscribe For A Premium Report To Maximize Your Returns

The FREE bio tech stock catalyst report ONLY includes companies with catalysts within the current week. Often, this may not be enough time to capture the pre-catalyst stock price movements. For MAX RETURNS. Subscribe to a premium report type below and you will receive reports with a longer outlook, allowing you to discover earlier entries to be positioned before a price move happens. Don’t miss out, maximize your return potential!

Choose your outlook window (each priced accordingly)

Get FREE Biotech Stock Catalyst Reports

Email